Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 6, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Intestine chip—remedy for “leaky” gut lining?

COVID UPDATE: Newly discovered tiny antibodies are completely defeating the menacing coronavirus

What if computers could understand or rather read your heart?

Intestine chip—remedy for “leaky” gut lining?
  • BiotechToday
  • World

Intestine chip—remedy for “leaky” gut lining?

bioxone September 16, 2020September 16, 2020

– Shrestha Dutta, Amity University Kolkata

As per a new analysis, carried out at the Quadram Institute, an exceptionally advanced “gut-on-chip” innovation demonstrated that the fermentation results of Human Milk Oligosaccharides (HMOs) made the gut lining less “faulty.” A flawed intestinal barrier has been connected to gut conditions, for example, Coeliac disease, Crohn’s disease, and irritable bowel syndrome. This research supports scientific evidence that HMOs might be utilized to establish systems to counter these conditions and improve gut health in adults. Human milk oligosaccharides (HMOs) are intricate indigestible sugars normally present in breast milk. They are notable for their pre-biotic impact in newborn children, where they provide nourishment for intestinal bacteria, particularly bifidobacteria. The predominance of these intestinal microorganisms in the gut assures a healthy intestinal microbiota and diminishes the risk of hazardous intestinal diseases in infants.

In addition to their advantageous role in infant health, an ongoing clinical preliminary demonstrated that two explicit HMOs, 2′- O-fucosyllactose (2’FL) and additionally Lacto-N-neotetraose (LNnT), are safe and well- endured in adults and are modulators of the adult gut microbiota with an addition in bifidobacteria. This recommends HMO supplementation might be a significant methodology to tweak health in adults.The Intestine-Chip is a miniature designed platform permitting the co-culture of epithelium cells that make up the gut fixing with tissue-explicit microvascular endothelial cells under microfluidic conditions. Utilizing this framework, they demonstrated a noteworthy increment of certain tight-junction proteins over each of the three gut-on-chips following treatment with fermented 2-‘FL. Taken together, this information demonstrated that in addition to supporting bifidobacterial development and a solid microbiota, HMOs can tweak immune function and the gut hindrance, supporting the capability of HMOs to give medical advantages in adults.

Source: Šuligoj T., Vigsnæs L.K., Abbeele P.V.D., Apostolou A., Karalis K., Savva G.M., McConnell B. , Juge N. (2020); Effects of Human Milk Oligosaccharides on the Adult Gut Microbiota and Barrier Function. Nutrients. DOI:10.3390/nu12092808

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged Human milk oligosaccharides immunity indigestible sugar infant health intestinal lining intestinal microbiota Intestine-Chip Lacto-N-neotetraose (LNnT) pre-biotics remedy

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

What if computers could understand or rather read your heart?

bioxone September 17, 2020

–Camelia Bhattacharyya, Amity University Kolkata Artificial intelligence, a very common term in the 21st century. It signifies the way in which machines stimulate the intelligence or rather the thinking abilities of humans . Artificial Intelligence runs along with machine learning which is the process of coding to make a computer learn data and use it. […]

Related Post

  • BiotechToday
  • World

Kyphoscoliotic Ehlers-Danlos Syndrome reported in China!

bioxone November 8, 2020November 8, 2020

Anannya Roy, Amity University Kolkata Autosomal Recessive Gene Disorders are the type of Genetic Disorders that are expressed only when two mutant copies of a gene are present in the organism.  Kyphoscoliotic Ehlers-Danlos Syndrome (kEDS) is an example of one such disorder that affects the connective tissues of a person’s body. This disorder was not […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Disease tolerance mechanism in sepsis patients identified!

bioxone October 18, 2020October 18, 2020

Prama Ghosh, Amity University Kolkata Sepsis, a complication caused by dysregulation of the immune system causes around 11 million deaths every year in the world. Treatment includes antibiotics and organ support measures, but it fails many times due to unsuccessful attempts at modulating the immune response. Surviving the condition requires activation of resistance mechanisms which […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Sandwich ELISA for detecting Canine Distemper virus

bioxone November 12, 2020November 11, 2020

Jayateerth S. Bhavikatti, CSIR-National Chemical Laboratory, Pune, India. Canine distemper virus (CDV), a highly contagious disease in animals, is responsible for the mortality of a variety of flesh-eating animals including Canidae, Procyonidae, Felidae, Mustelidae, etc. This infection leads to complications in gastrointestinal, respiratory, and neurological parts of their bodies. The infection has been witnessed in […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy